Clinical features and recurrence predictors of histiocytic necrotizing lymphadenitis in Chinese children.


Journal

Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897

Informations de publication

Date de publication:
11 Jun 2024
Historique:
received: 11 02 2024
accepted: 30 05 2024
medline: 12 6 2024
pubmed: 12 6 2024
entrez: 11 6 2024
Statut: epublish

Résumé

To characterize the clinical features and to identify the predictors of recurrence of histiocytic necrotizing lymphadenitis (HNL) in Chinese children. This study retrospectively analyzed the clinical characteristics, laboratory and pathological findings, and recurrence status of children diagnosed with HNL at a single center in China from January 2018 to May 2023. Logistic regression analysis was employed to identify predictors of HNL recurrence. 181 Chinese children with histopathologically confirmed HNL were enrolled (121 males and 60 females). The mean age was 9.3 ± 2.9 years. The most prominent clinical features were fever (98.9%) and cervical lymphadenopathy (98.3%). Aseptic meningitis was the most frequent complication (38.5%), while hemophagocytic lymphohistiocytosis and autoimmune disease were rare (1.7% and 1.2%, respectively). Recurrence occurred in 12.7% of patients. Erythrocyte sedimentation rate (> 30 mm/h) was the significant predictors of HNL recurrence, with odds ratios of 6.107, respectively. Our study demonstrates that fever and cervical lymphadenopathy are the most frequent clinical manifestations of HNL in Chinese children, which often coexist with aseptic meningitis. HNL patients with risk factors require follow-up for recurrence.

Identifiants

pubmed: 38862943
doi: 10.1186/s12969-024-00996-y
pii: 10.1186/s12969-024-00996-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

61

Subventions

Organisme : National Regional Medical Center Opening Project
ID : NRMC0107

Informations de copyright

© 2024. The Author(s).

Références

Pepe F, Disma S, Teodoro C, Pepe P, Magro G. Kikuchi-Fujimoto disease: a clinicopathologic update. Pathologica. 2016;108(3):120–9. PMID: 28195263.
pubmed: 28195263
Lelii M, Senatore L, Amodeo I, Pinzani R, Torretta S, Fiori S, Marchisio P, Bosis S. Kikuchi-Fujimoto disease in children: two case reports and a review of the literature. Ital J Pediatr. 2018;44(1):83. https://doi.org/10.1186/s13052-018-0522-9 . PMID: 30021595; PMCID: PMC6052688.
doi: 10.1186/s13052-018-0522-9 pubmed: 30021595 pmcid: 6052688
Jung HJ, Lee IJ, Yoon SH. Risk assessment of recurrence and autoimmune disorders in Kikuchi disease. Risk Manag Healthc Policy. 2020;13:1687–93. https://doi.org/10.2147/RMHP.S271283 . PMID: 33061702; PMCID: PMC7519817.
doi: 10.2147/RMHP.S271283 pubmed: 33061702 pmcid: 7519817
Kang HM, Kim JY, Choi EH, Lee HJ, Yun KW, Lee H. Clinical characteristics of severe histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto Disease) in children. J Pediatr. 2016;171:208 – 12.e1. https://doi.org/10.1016/j.jpeds.2015.12.064 . Epub 2016 Feb 4. PMID: 26852178.
Masab M, Surmachevska N, Farooq H, Kikuchi D. 2022 Jun 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 28613580.
Yoo IH, Na H, Bae EY, Han SB, Lee SY, Jeong DC, Kang JH. Recurrent lymphadenopathy in children with Kikuchi-Fujimoto disease. Eur J Pediatr. 2014;173(9):1193–9. https://doi.org/10.1007/s00431-014-2306-6 . Epub 2014 Apr 9. PMID: 24714877.
doi: 10.1007/s00431-014-2306-6 pubmed: 24714877
Abdu A, Pajkrt D, Bijker EM. Kikuchi disease in children: Case report and review of the literature. Pediatr Infect Dis J. 2022;41(3):199–204. https://doi.org/10.1097/INF.0000000000003397 . PMID: 34862340.
Kim HY, Jo HY, Kim SH. Clinical and laboratory characteristics of Kikuchi-Fujimoto Disease according to Age. Front Pediatr. 2021;9:745506. https://doi.org/10.3389/fped.2021.745506 . PMID: 34796153; PMCID: PMC8593182.
doi: 10.3389/fped.2021.745506 pubmed: 34796153 pmcid: 8593182
Zaccarelli F, de Vincentiis M, D’Erme G, Greco A, Natalucci F, Fusconi M. Kikuchi-Fujimoto Disease: A Distinct Pathological Entity but also an Overlap Autoimmune Syndrome: A Systematic Review. Curr Rheumatol Rev. 2023;19(2):159–167. https://doi.org/10.2174/1573397118666220903123128 . PMID: 36056828.
Shahrokh S, Hasan A, Alim S, Hebert M, Rizvi K. Kikuchi-Fujimoto Disease complicated by rheumatoid arthritis, type 1 diabetes Mellitus, and Hypothyroidism. Cureus. 2022;14(1):e21008. https://doi.org/10.7759/cureus.21008 . PMID: 35154980; PMCID: PMC8818265.
doi: 10.7759/cureus.21008 pubmed: 35154980 pmcid: 8818265
Shukla B, Aguilera EA, Salazar L, Wootton SH, Kaewpoowat Q, Hasbun R. Aseptic meningitis in adults and children: diagnostic and management challenges. J Clin Virol. 2017;94:110–4. https://doi.org/10.1016/j.jcv.2017.07.016 . Epub 2017 Aug 4. PMID: 28806629; PMCID: PMC5581214.
doi: 10.1016/j.jcv.2017.07.016 pubmed: 28806629 pmcid: 5581214
Song Y, Liu S, Song L, Chen H, Bai M, Yan J, Luo T, Liu K, Sun L, Zhao Y. Case Report: Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) Concurrent with aseptic meningitis. Front Neurol. 2021;12:565387. https://doi.org/10.3389/fneur.2021.565387 . PMID: 33959084; PMCID: PMC8093430.
doi: 10.3389/fneur.2021.565387 pubmed: 33959084 pmcid: 8093430
Yang Y, Lian H, Ma H, Zhao Y, Zhang Q, Zhang L, Wang T, Li Z, Zhang R. Hemophagocytic Lymphohistiocytosis Associated with Histiocytic Necrotizing lymphadenitis: a clinical study of 13 Children and Literature Review. J Pediatr. 2021;229:267–e2743. Epub 2020 Sep 18. PMID: 32956695.
doi: 10.1016/j.jpeds.2020.08.063 pubmed: 32956695
Shen Z, Ling J, Zhu X, Yang J, He T. Macrophage activation syndrome in children with Kikuchi-Fujimoto disease. Pediatr Rheumatol Online J. 2023;21(1):10. https://doi.org/10.1186/s12969-023-00788-w . PMID: 36698152; PMCID: PMC9875483.
doi: 10.1186/s12969-023-00788-w pubmed: 36698152 pmcid: 9875483
Zhou KG, Gong DH, Peng D, Wang ZQ, Huang W. Clinical profile, etiology, and outcome of hemophagocytic lymphohistiocytosis associated with histiocytic necrotizing lymphadenitis. World J Pediatr. 2023;19(4):406–10. https://doi.org/10.1007/s12519-022-00660-z . Epub 2023 Jan 3. PMID: 36595187; PMCID: PMC10060272.
doi: 10.1007/s12519-022-00660-z pubmed: 36595187 pmcid: 10060272
Selvanathan SN, Suhumaran S, Sahu VK, Chong CY, Tan NWH, Thoon KC. Kikuchi-Fujimoto disease in children. J Paediatr Child Health. 2020;56(3):389–393. https://doi.org/10.1111/jpc.14628 . Epub 2019 Oct 1. PMID: 31576642.
Zhang D, Su GX, Wu FQ, Zhu J, Kang M, Xu YJ, Li M, Lai JM. [Clinical features and prognosis of 118 children with histiocytic necrotizing lymphadenitis]. Zhonghua Er Ke Za Zhi. 2023;61(6):533–537. Chinese. https://doi.org/10.3760/cma.j.cn112140-20230110-00020 . PMID: 37312465.
Song JY, Lee J, Park DW, Sohn JW, Suh SI, Kim IS, Kim WJ, Kim MJ, Cheong HJ. Clinical outcome and predictive factors of recurrence among patients with Kikuchi’s disease. Int J Infect Dis. 2009;13(3):322–6. https://doi.org/10.1016/j.ijid.2008.06.022 . Epub 2009 Feb 8. PMID: 19208493.
doi: 10.1016/j.ijid.2008.06.022 pubmed: 19208493
Perry AM, Choi SM. Kikuchi-Fujimoto Disease: A Review. Arch Pathol Lab Med. 2018;142(11):1341–1346. https://doi.org/10.5858/arpa.2018-0219-RA . PMID: 30407860.
Lin YC, Huang HH, Nong BR, Liu PY, Chen YY, Huang YF, Chiou YH, Lee HS. Pediatric Kikuchi-Fujimoto disease: a clinicopathologic study and the therapeutic effects of hydroxychloroquine. J Microbiol Immunol Infect. 2019;52(3):395–401. Epub 2017 Sep 29. PMID: 29050748.
doi: 10.1016/j.jmii.2017.08.023 pubmed: 29050748
Faheem B, Kumar V, Ashkar H, Komal F, Sultana Y. Recurrent Kikuchi-Fujimoto Disease Masquerading as Lymphoma successfully treated by Anakinra. Cureus. 2020;12(11):e11655. https://doi.org/10.7759/cureus.11655 . PMID: 33391894; PMCID: PMC7769493.
doi: 10.7759/cureus.11655 pubmed: 33391894 pmcid: 7769493

Auteurs

Xiaoning Zhang (X)

Respiratory Department, Children's Hospital Affiliated to Zhengzhou University, Henan Children's hospital, Zhengzhou Children's Hospital, Zhengzhou, 450008, China.

Xiuhong Jin (X)

Respiratory Department, Children's Hospital Affiliated to Zhengzhou University, Henan Children's hospital, Zhengzhou Children's Hospital, Zhengzhou, 450008, China.

Xiangfeng Zhang (X)

Respiratory Department, Children's Hospital Affiliated to Zhengzhou University, Henan Children's hospital, Zhengzhou Children's Hospital, Zhengzhou, 450008, China.

Yuelin Shen (Y)

Respiratory Department II, National Clinical Research Center for Respiratory Diseases, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, NO.56, Nanlishi Road, Beijing, 100045, China. shenyuelin@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH